الملخص
Con el objetivo de determinar la correlación entre los casos de varicela notificados en Perú y las búsquedas sobre varicela realizadas en Google a nivel nacional y por regiones se realizaron análisis de correlación de Spearman para las semanas epidemiológicas del 2016 al 2019, así como antes y después de la introducción de la vacuna para varicela en el Perú. A nivel nacional, se encontró una alta correlación antes del inicio de la vacunación (Rho 0,778, p = 0,001) y moderada durante el periodo de vacunación (Rho 0,441, p = 0,001). Algunas regiones tuvieron una correlación baja o muy baja y dejaron de ser estadísticamente significativas luego de la introducción de la vacuna en el Perú. Además, el cambio en la estacionalidad de la varicela durante el periodo de vacunación también tuvo un impacto en las búsquedas que realiza la población en Google.
Abstract In order to determine if there is a correlation between chickenpox cases reported in Peru and the chickenpox searches carried out on Google at national level and by regions, Spearman's correlation analyzes were carried out for the epidemiological weeks from 2016 to 2019, as well as before and after the introduction of the chickenpox vaccine in Peru. At the national level, a high correlation was found before the start of vaccination (Rho 0.778, p = 0.001) and moderate during the vaccination period (Rho 0.441, p = 0.001), some regions had a low or very low correlation and stopped to be statistically significant after the introduction of the vaccine in Peru. In addition, the change in the seasonality of chickenpox during the vaccination period also had an impact on the searches carried out by the population on Google.
الموضوعات
Humans , Chickenpox/epidemiology , Search Engine/trends , Peru/epidemiology , Chickenpox/prevention & control , Chickenpox Vaccine/administration & dosage , Internet , Ecological Studies , Epidemiological Monitoring , Correlation of Dataالملخص
Objetivo: Descrever o surto de varicela entre imigrantes venezuelanos em abrigos e ocupações nos municípios de Pacaraima e Boa Vista, Roraima, Brasil, e as medidas de controle implementadas. Métodos: Estudo descritivo do tipo 'série de casos', realizado entre 21 de novembro e 13 de dezembro de 2019, sobre banco de dados secundários da investigação do surto disponibilizado pela Coordenação-Geral do Programa Nacional de Imunizações. Na análise descritiva, utilizaram-se medidas de frequência simples e relativa e foram calculadas medidas de tendência central e dispersão. Resultados: Dos 9.591 imigrantes, detectaram-se 38 casos ativos e 1.459 suscetíveis à varicela. Dos casos ativos, 23 eram do sexo feminino e a faixa etária mais acometida foi a de menores de 9 anos (17 casos). Conclusão: Identificaram-se pessoas suscetíveis a varicela na investigação; foram adotadas ações de imunização que controlaram a transmissão, evitando casos graves, óbitos e sobrecarga da rede de assistência à saúde local.
Objetivo: Describir el brote de varicela entre inmigrantes venezolanos en albergues y ocupaciones en los municipios de Pacaraima y Boa Vista, Roraima, Brasil, y las medidas de control implementadas. Métodos: Estudio descriptivo del tipo "serie de casos", entre el 21 de noviembre y 13 de diciembre de 2019, utilizando datos secundarios de la investigación del brote, puesto a disposición por la Coordinación General del Programa Nacional de Inmunizaciones. En el análisis descriptivo, se utilizaron medidas de frecuencia simple y relativa y se calcularon medidas de tendencia central y dispersión. Resultados: Entre los 9.591 inmigrantes se detectaron 38 casos activos y 1.500 susceptibles a la varicela. Entre los casos activos, 23 fueron mujeres y el grupo de edad más afectado fue de menores de 9 años (17 casos). Conclusión: Se identificaron personas susceptibles a la varicela, lo que llevó a adopción de acciones de inmunización que controlaran la transmisión, previniendo casos graves, muertes y sobrecarga de la red local de atención.
Objective: To describe chickenpox outbreak among Venezuelan immigrants in shelters and occupancies in the municipalities of Pacaraima and Boa Vista, the state capital of Roraima, Brazil, and the control measures implemented. Methods: This was a descriptive case series study, conducted between November 21 and December 13, 2019, based on secondary database obtained from the outbreak investigation made available by the General Coordination for the National Immunization Program. Descriptive analysis was performed using simple and relative frequency measurements, and measures of central tendency and dispersion were calculated. Results: Of the 9,591 immigrants, 38 active cases and 1,459 susceptible to varicella were identified. With regard to active cases, 23 were female, and those aged under 9 years (17 cases) were the most affected. Conclusion: People susceptible to chickenpox were identified during the investigation. Immunization actions aimed at reducing transmission were adopted, thus preventing severe cases, deaths and overload in local health care system.
الموضوعات
Humans , Male , Female , Chickenpox/prevention & control , Chickenpox/epidemiology , Disease Outbreaks , Emigrants and Immigrants , Venezuela/ethnology , Brazil , Immunization , Vaccination , Refugee Campsالملخص
ABSTRACT Objective: To assess the number of cases and the profile of hospitalizations from varicella after the introduction of the measles, mumps, rubella and varicella combination vaccine in the public health system. Methods: Retrospective study in an infectious diseases pediatric hospital of reference in Southeast Brazil. The cases with a clinical diagnosis of varicella, from January 2011 to June 2016, were assessed from pediatricians' medical records. The hospitalizations were classified into a pre-vaccine group and post-vaccine group, based on the date the vaccine was introduced (September 2013). Both groups were compared by age, sex, time of hospitalization, reason for hospitalization, hospital complications, duration of intensive care, and clinical outcome. Results: A total of 830 hospitalizations were recorded; 543 in the pre-vaccine period and 287 in the post-vaccine period, a reduction of 47.1% (p<0.001). In both periods, a similar profile in the hospitalizations was noticed: majority male; aged between one to five years old; most complications due to secondary causes (mainly skin infections); main outcome was clinical improvement and discharge from the hospital. In the pre-vaccine period, six deaths were recorded and two were recorded in the post-vaccine period. Conclusions: The profile of the hospitalizations was expected to stay the same since this study did not compare vaccinated with unvaccinated children, but hospitalizations before and after the vaccine was introduced. In accordance with the medical literature, we found a significant fall in the number of hospitalizations from varicella.
RESUMO Objetivo: Avaliar o número de casos e o perfil das internações por varicela após a introdução da vacina quádrupla viral na rede pública. Métodos: Estudo retrospectivo conduzido em hospital pediátrico referência em doenças infectocontagiosas na Região Sudeste do Brasil. Foram avaliados os casos com diagnóstico clínico de varicela, registrados em prontuário por médico pediatra, de janeiro de 2011 até junho de 2016. As internações foram classificadas em grupo pré-vacinal e grupo pós-vacinal, com base na data de introdução da vacina (setembro de 2013). Os grupos foram comparados em relação a: faixa etária, sexo, tempo de hospitalização, causas da internação, complicações hospitalares, tempo da internação em terapia intensiva e desfecho clínico. Resultados: Foram documentadas 830 internações, 543 no período pré-vacinal e 287 no pós-vacinal, ocorrendo redução de 47,1% nas internações (p<0,001). Em ambos os períodos, notou-se um perfil similar das internações, predominantemente: sexo masculino; faixa etária de um a cinco anos; por causas secundárias (principalmente infecções de pele); evoluindo com melhora clínica e alta hospitalar. Em relação ao número de óbitos, ocorreram seis no período pré-vacinal e dois no pós-vacinal. Conclusões: A manutenção do perfil das internações era esperada, visto que o trabalho não comparou crianças vacinadas com não vacinadas, e sim internações pré e pós-vacinais. Observou-se, em concordância com a literatura, queda substancial no número de internações por varicela.
الموضوعات
Humans , Male , Female , Infant , Child, Preschool , Child , Chickenpox/epidemiology , Chickenpox Vaccine/administration & dosage , Length of Stay/statistics & numerical data , Brazil/epidemiology , Retrospective Studies , Vaccination , Vaccines, Combined , Measles-Mumps-Rubella Vaccineالملخص
Abstract Objective: To describe the impact of the introduction of the viral tetra vaccine in the National Immunization Program in 2013 for 15-month-old children in mortality rates and hospitalization associated with varicella in Brazil. Methods: Mortality rates and hospitalizations rates associated with varicella were evaluated between 2010 and 2016 and described according to Brazilian macro regions and age. The population was stratified into age groups: < 1 year, 1-4 years, and 5-14 years. Data were collected from the Informatics Department of the Unified Health System. A percentage difference was calculated between rates of hospitalizations and mortality in the pre (2010-2012) and post-vaccination periods (2014-2016) to estimate the approximate effectiveness of the vaccine. Data synthesis: At the national level, vaccination significantly reduced the mortality rates and hospitalizations rates in all age groups analyzed. Among those under 5 years of age, mortality rates and hospitalizations rates decreased 57-49% and 40-47%, respectively. There was a national decrease of up to 57% in the mortality rates due to the disease, with smaller decreases seen in the North and Northeast regions and the largest in the South and Southeast regions. The hospitalizations rates for varicella reached a maximum national decline of 47%. In children aged 1-4 years, with higher vaccination coverage, the highest reduction was observed in both mortality rates and hospitalizations rates, which decreased from 2.6 to 0.4/100,000/year. Conclusions: The tetra vaccine proved to be effective in reducing both mortality and hospitalizations of children and adolescents up to 15 years of age in the 2014-2016 triennium.
Resumo Objetivo: Descrever o impacto da introdução da vacina tetra viral no Programa Nacional de Imunização em 2013 para crianças de 15 meses nas taxas de mortalidade e de internação hospitalar associadas à varicela no Brasil. Métodos: As taxas de mortalidade e de internação hospitalar associadas à varicela foram avaliadas entre 2010 e 2016 e descritas conforme macrorregiões brasileiras e idade. A população foi estratificada em grupos etários: < 1 ano; 1-4 e 5-14 anos. Os dados foram coletados do Departamento de Informática do Sistema Unificado de Saúde. Foi realizado um cálculo de diferença percentual entre taxas de internações e mortalidade nos períodos pré (2010-2012) e pós-vacinal (2014-2016) para estimativa de impacto da vacina. Resultados: No nível nacional, a vacinação reduziu significativamente as taxas de mortalidade e de internação hospitalar em todas faixas etárias analisadas. Entre os menores de 5 anos, a taxas de mortalidade e de internação hospitalar diminuíram 57-49% e 40-47%, respectivamente. Houve uma queda nacional de até 57% nos índices de mortalidade pela doença, com menores quedas vistas nas regiões Norte e Nordeste e as maiores nas regiões Sul e Sudeste. As taxas de internação hospitalar por varicela atingiram queda nacional máxima de 47%. Em crianças de 1-4 anos, com maior cobertura vacinal, foi observada a maior redução tanto na taxa de internação hospitalar como na taxa de mortalidade, a qual passou de 2,6 para 0,4/100.000/ano. Conclusões: A vacinação se mostrou efetiva em reduzir tanto mortalidade quanto hospitalizações das crianças e adolescentes de até 15 anos no triênio 2014-2016.
الموضوعات
Humans , Infant , Child, Preschool , Child , Adolescent , Viral Vaccines , Chickenpox/prevention & control , Chickenpox/epidemiology , Chickenpox Vaccine , Brazil/epidemiology , Morbidity , Vaccination , Hospitalizationالملخص
Se estima que más del 90 % de la población mundial susceptible ha padecido varicela antes de los 15 años. En Honduras son escasos los estudios realizados sobre esta enfermedad. Objetivo: establecer las características clínico-epidemiológicas de varicela en población afectada de la Región Sanitaria Metropolitana del Distrito Central, del 1 de enero al 31 de diciembre 2016. Material y Métodos: estudio transversal; universo de 2 885 casos reportados a la unidad de vigilancia de la Región Sanitaria Metropolitana del Distrito Central. Se estudiaron 343 casos, los cuales se seleccionaron proporcionalmente según el número de casos por establecimientos de salud de procedencia. Se creó una ficha y una base de datos en MS Excel, el análisis se hizo usando Epi Info. Resultados: la mayoría de los casos tenían menos de 12 años de edad, los grupos más afectados fueron los de 0 a 5 años, 153(44.9%) y los de 6 a 12 años, 113(33.1%), la media de edad fue de 9.2 años ± 10 años 1DE. Un tercio fue atendido a nivel hospitalario; en el Instituto Hondureño de Seguridad Social 109(31.8%), 4(1.2%) en el Hospital San Felipe y 2(0.6%) en el Hospital Escuela Universitario. La media de duración de la fiebre sin complicaciones fue 2.1 días ± 1.2 días. Uno de cada 10 casos presentó alguna complicación, entre éstas, las enfermedades respiratorias superiores (6.4%) y lesiones de piel (1.5%) y los menores de 6 años tendieron a sufrir complicaciones. 74% recibió antipiréticos/antiinflamatorios, 47.6% antihistamínicos y 25.1% antibióticos. La prescripción de antibióticos fue significativamente mayor para casos con complicaciones (OR=17.9, IC95% 7.3-44.0), al igual que analgésicos y antipiréticos (OR=2.8, IC95% 1-8.3). Conclusiones: la población más afectada fueron los niños menores de 12 años y las complicaciones se observaron en niños menores de 6 años. El uso de antibióticos y analgésicos fue mayor en casos con complicaciones. Los hallazgos del estudio apoyan la importancia de considerar la inclusión de la vacuna contra varicela en el esquema nacional de inmunizaciones...(AU)
الموضوعات
Humans , Male , Female , Child, Preschool , Child , Adolescent , Adult , Middle Aged , Aged , Physicians' Offices , Chickenpox/epidemiology , Varicellovirus , State Health Surveillance Centersالملخص
Abstract: Varicella in adults and immunocompromised patients can be severe. The clinical diagnosis of varicella has high accuracy and the history of disease has a high positive predictive value for protection. A significant portion of adults, however, cannot remember if they have had varicella, especially older individuals. We conducted a cross-sectional study to determine the seroprevalence of varicella protective antibodies titers in adults with no clinical history of disease, attended at a Reference Center for Special Immunobiologicals and Travel Medicine in Rio de Janeiro (Brazil). Titration of immunoglobulin G (IgG) antibodies to varicella-zoster was determined by chemiluminescence immunoassay. Among 140 adults without history of varicella, 92% had protective antibody titers. We concluded that seroprevalence of varicella-zoster protection was very high in adults with negative history of disease and the use of serology before vaccination reduced significantly unnecessary vaccine and immunoglobulin use.
Resumo: A varicela é uma doença potencialmente grave em adultos e em pacientes imunocomprometidos. O diagnóstico clínico da varicela apresenta alta acurácia, e o relato da doença na história individual tem alto valor preditivo positivo para a proteção. Entretanto, uma proporção significativa de adultos, principalmente os mais idosos, não se lembra se já teve a doença. Realizamos um estudo transversal para determinar a soroprevalência de títulos protetores de anticorpos contra a varicela em adultos sem história clínica da doença, atendidos em um Centro de Referência para Imunobiológicos Especiais e Medicina de Viagem no Rio de Janeiro, Brasil. Os títulos da imunoglobulina G (IgG) contra varicela-zoster foram determinados por quimiluminescência. Entre 140 adultos sem história de varicela, 92% apresentaram títulos protetores de anticorpos. Concluímos que a soroprevalência de proteção contra varicela-zoster é muito alta em adultos sem história da doença, e que o uso de teste sorológico antes da vacinação reduziria significativamente a vacinação desnecessária e o uso de imunoglobulina.
Resumen: La varicela en adultos y pacientes inmunocomprometidos puede ser grave. El diagnóstico clínico de la varicela tiene una gran precisión y la historia de la enfermedad cuenta con un alto valor predictivo positivo para la protección contra ella. Sin embargo, un porcentaje significativo de adultos, no puede recordar si tuvieron varicela, especialmente las personas más viejas. Realizamos un estudio transversal para determinar la seroprevalencia de las concentraciones de anticuerpos protectores frente a la varicela, en adultos sin historia clínica de la enfermedad, que se llevó a cabo en un Centro de Referencia para Inmunobiología Especial y Medicina del Viajero en Río de Janeiro (Brasil). Se determinó la valoración de los anticuerpos de inmunoglobulina G (IgG) a la varicela-zoster mediante un ensayo inmunológico quimioluminiscente. Entre 140 adultos sin historial de varicela, un 92% tuvieron concentraciones de anticuerpos protectores. Concluimos que la seroprevalencia de la protección a la varicela-zoster fue muy alta en adultos con un historial negativo de la enfermedad y la utilización de la serología antes de la vacunación redujo de manera significativa la vacunación innecesaria y el uso de la inmunoglobulina.
الموضوعات
Humans , Adult , Immunoglobulin G/blood , Chickenpox/epidemiology , Herpesvirus 3, Human/immunology , Brazil/epidemiology , Chickenpox/prevention & control , Chickenpox/blood , Prevalence , Cross-Sectional Studies , Chickenpox Vaccine , Luminescent Measurements , Antibodies, Viral/bloodالملخص
Introducción. En Argentina, se estiman 400 000 casos anuales de varicela. Dado el subregistro de casos existentes, la carga de enfermedad real se desconoce. Objetivo. Evaluar la carga de enfermedad por varicela antes de la introducción de la vacuna al Calendario Nacional. Materiales y métodos. Estudio retrospectivo, analítico, observacional, realizado en tres centros asistenciales del país. Revisión de los registros de consultas ambulatorias a los Servicios de Urgencias y de las historias clínicas de las internaciones por varicela en pacientes < 18 años. Período: 1/2011-12/2013. Resultados. Fueron asistidas un total de 382782 consultas ambulatorias; 3367 (0,88 %) correspondieron a consultas por varicela; el 57,6 %, < 4 años. Requirieron internación 164 (4,9 %) con una tasa de hospitalización global de 65,3/10000 hospitalizados/año (IC 95 %: 55,4-76,5); tasa de hospitalización en niños sanos: 57,2/10 000 (IC 95 %: 67,7-48,0); mediana de edad: 31,5 meses. Las causas de internación más frecuentes fueron infecciones de piel y/o partes blandas (61,1 %) y respiratorias (10,1 %). El 54,3 % recibió tratamiento con aciclovir, y el 73,1 %, con antibióticos. Presentaron bacteriemia 5/67 (7,5 %), todas por cocos Gram(+) y en inmunocompetentes. De los 19 pacientes inmunocomprometidos, el 36,8 % tuvo complicaciones (5 infecciones de piel y/o partes blandas y 2 neumonías). La mediana de días de internación fue 4, significativamente más prolongada en pacientes inmunocomprometidos. Un paciente requirió cuidados intensivos. No hubo fallecidos. Conclusión. La carga de enfermedad registrada fue significativa, con impacto considerable en pacientes sin patología de base.
Introduction. In Argentina, an estimated 400 000 varicella cases occur annually. Given the under-recording of existing cases, the actual burden of disease is unknown. Objective. To assess the burden of varicella before the introduction of the varicella vaccine in the national immunization schedule. Materials and methods. Retrospective, analytical, observational study carried out in three hospitals of Argentina. Review of medical records from outpatient visits to the Emergency Department and from patients younger than 18 years hospitalized for varicella. Period: 1/2011-12/2013. Results. A total of 382 782 outpatients were seen; 3367(0.88%) corresponded to visits due to varicella; 57.6 % were < 4 years old. A total of 164 (4.9 %) patients required hospitalization, with an overall hospitalization rate of 65.3/10 000 hospitalized patients/year (95 % confidence interval -#91;CI-#93;: 55.4-76.5); hospitalization rate in healthy children: 57.2/10 000 (95 % CI: 67.7-48.0); median age: 31.5 months. The most common causes of hospitalization were skin and/or soft tissue infections (61.1 %) and respiratory infections (10.1 %). Also, 54.3 % were treated with acyclovir and 73.1 %, with antibiotics. Bacteremia developed in 5/67 patients (7.5 %), all cases were caused by Gram-positive cocci and occurred in immunocompetent patients. Out of 19 immunocompromised patients, 36.8 % had complications (5 skin and/or soft tissue infection and 2 pneumonia cases). The median length of stay was 4 days, which is significantly more prolonged in immunocompromised patients. One patient required intensive care. No patient died. Conclusion. The burden of disease was significant, with a considerable impact in patients without an underlying disease.
الموضوعات
Humans , Infant , Child, Preschool , Child , Adolescent , Chickenpox/epidemiology , Cost of Illness , Argentina/epidemiology , Chickenpox/diagnosis , Chickenpox/drug therapy , Retrospective Studies , Ambulatory Care , Hospitalizationالملخص
Abstract INTRODUCTION: This study aimed to analyze cases of complicated varicella and the impact of varicella vaccination in Minas Gerais, Brazil. METHODS: This was a time series study of a territorial basis using data on varicella cases from 2010 to 2016, which was provided by the State Health Department of Minas Gerais on . Descriptive statistics were used for the analysis, and the generalized linear regression model proposed by Prais-Winsten was used for the time tendency, adopting a significance level of 5% and the integrated autoregressive modeling of moving averages. RESULTS: There were 1,635 cases of varicella; out of which cellulitis (44%) was the predominant complication. The home-acquired cases were 38.9% and 464 cases (40.6%) were not previously vaccinated. There was a significant decrease in the incidence coefficient when comparing the pre- and post- immunization periods, from 1.95 cases/100,000 inhabitants in 2010 to 0.24 cases/100.000 inhabitants in 2016 (p<0.05). There was a higher incidence of cases recorded among males, with higher prevalence in the age group of 1-4 years (54.7%). Lethality was higher between 5-9 years of age (44%). Mortality was higher in the age group of 0-4 years and among females (2.58/100,000 inhabitants/year). The overall trend of the incidence coefficient was a decreasing one, with an annual percentage variation. CONCLUSIONS: The number of complicated varicella cases notified decreased, coincidentally, in the post-immunization period. However, the immunization coverage period was restricted for the assessment of the correlation between immunization coverage and incidence.
الموضوعات
Humans , Male , Female , Pregnancy , Infant , Child, Preschool , Child , Adolescent , Adult , Aged , Aged, 80 and over , Chickenpox/epidemiology , Vaccination/statistics & numerical data , Hospitalization/statistics & numerical data , Seasons , Socioeconomic Factors , Brazil/epidemiology , Chickenpox/prevention & control , Incidence , Spatio-Temporal Analysis , Middle Agedالملخص
Since beginning of the year 2018, the WHO Eastern Mediterranean Region [EMR] has experienced ongoing and new outbreaks of emerging and re-emerging infectious disease in many countries. A number of these outbreaks are continuing from the previous year
الموضوعات
Humans , Infant, Newborn , Infant , Child, Preschool , Child , Adolescent , Adult , Middle Aged , Cholera/epidemiology , Diphtheria/epidemiology , Hemorrhagic Fever, Crimean/epidemiology , Typhoid Fever/epidemiology , Middle East Respiratory Syndrome Coronavirus , Chickenpox/epidemiologyالملخص
Resumen: Objetivo: Evaluar el comportamiento epidemiológico de la varicela y el herpes zoster (HZ) para determinar políticas de salud y disminuir prevalencia y complicaciones. Material y métodos: La frecuencia de casos se estimó con datos del Sistema Único de Información para la Vigilancia Epidemiológica (SUIVE), periodo 2000-2013; para los egresos hospitalarios de varicela y HZ, se utilizaron datos del Sistema Nacional de Información en Salud (Sinais). Resultados: El promedio de casos de varicela anual fue 296 733, 57% menores de 9 años, la mayoría de marzo a mayo; de 2004 a 2012 los egresos hospitalarios de varicela fueron 17 398, de ellos 4.6% presentó meningoecefalitis, 2.5% neumonía y 18% otras complicaciones. Por herpes zoster 7 042 egresos, más afectados de 65 años o más, 1.3:1 la relación mujer:hombre. Las complicaciones: neuralgia (11%), afección ocular (7%), meningoencefalitis (5.4%), enfermedad diseminada (2.8%) y otras (5.4%); estancia hospitalaria entre 6.4 a 13.3 días. Conclusiones: Los datos coinciden con los de la literatura de otros países. Se discute el papel de la vacunación en la prevención de la infección en niños y adultos.
Abstract: Objective: To evaluate the epidemiological behavior of varicella and herpes zoster (HZ) to determine the need of health policies to diminish prevalence and avoid complications. Materials and methods: To assess frequency, we analyzed data from the National Information System for Epidemiological Surveillance (SUIVE) from 2000 to 2013; to assess the discharge data of varicella and HZ, we evaluated information from the National System of health information (Sinais). Results: The average annual cases of chickenpox were 296 733, 57% mostly children under 9 years, most of them from March to May. From 2004 to 2012 hospital discharge of varicella were 17 398, of which 4.6% had meningoecephalitis, 2.5% pneumonia and 18% other complications. For herpes zoster 7 042 discharges, mostly affected were patients 65 years or older, 1.3:1 the woman-man relationship. Main complications were: neuralgia (11%), eye involvement (7%), meningoencephalitis (5.4%), disseminated disease (2.8%) and others (5.4%); hospital stay was between 6.4 and 13.3 days. Conclusions: Data is consistent with that of the literature in other countries. The role of vaccination to prevent infection in children and adults is discussed.
الموضوعات
Humans , Male , Female , Middle Aged , Aged , Chickenpox/epidemiology , Herpes Zoster/epidemiology , Patient Discharge/statistics & numerical data , Seasons , Chickenpox/complications , Chickenpox/prevention & control , Public Health , Prevalence , Encephalitis, Herpes Simplex/epidemiology , Geography, Medical , Health Policy , Health Services Needs and Demand , Herpes Zoster/complications , Length of Stay , Neuralgia/epidemiologyالملخص
A varicela é uma doença viral, aguda, causada pela infecção primária pelovírus varicela zoster (VZV). Embora a maior parte dos casos de varicela seja benigna,a doença pode associar-se a complicações que levam à hospitalização e óbito, comopneumonias, meningoencefalites e infecções bacterianas secundárias. Anos apósa infecção primária pelo VZV, pode ocorrer reativação viral, que se manifesta comoherpes zoster. Iniciou-se, em 2013, no Brasil, a vacinação universal contra a varicela,através do Programa Nacional de Imunizações. A eficácia da vacina varia entre 70 e 90%.Tem sido considerada a hipótese de que a vacinação universal contra a varicela podeocasionar mudança no perfil epidemiológico da doença, com aumento do número de casosem adolescentes e adultos, além de influenciar a incidência do herpes zoster. O presenteestudo tem como objetivo caracterizar a mortalidade e morbidade hospitalar, associadasao VZV no período pré-vacinal no Brasil, gerando um diagnóstico de situação que possaser utilizado para comparações no período pós-vacinal. Foram realizados dois estudos:inicialmente, dados secundários foram coletados a partir do Sistema de Informações deSaúde (Tabnet) do Departamento de Informática do Sistema Único de Saúde (DataSUS)para cálculo das taxas de mortalidade por varicela por região e por ano, no período entre1996 e 2011, e das taxas de hospitalização por varicela e herpes zoster por região epor ano, no período entre 2008 e 2013. Os resultados foram estratificados por idade eas distribuições temporal e geográfica caracterizadas...
Varicella is a viral disease induced by a primary varicella zoster virus (VZV)infection. While most cases of the disease are benign, it can originate complicationsleading to hospitalization and death, like pneumonia, secondary bacterial infections andmeningoencephalitis. Many years after primary VZV infection, viral reactivation manifestedas herpes zoster can occur. Universal varicella vaccination began in 2013 in Brazil throughthe National Immunization Program. Vaccine efficacy is between 70 and 90%. It has beenhypothesized that vaccination against chickenpox can change disease epidemiology, withan increased number of cases in adolescents and adults. There is also concern about theimpact of universal vaccination on herpes zoster incidence. The present study aims tocharacterize the morbidity and hospital mortality associated with VZV in the pre-vaccineperiod in Brazil, generating a situation analysis that can be used as a benchmark forcomparisons in the post-vaccine period. Two studies were performed: initially, secondarydata were collected from the Health Information System (Tabnet) of the Department of theUnified Health System (DataSUS) for mortality rates calculation for varicella by region andyear between 1996 and 2011, and hospitalization rates for varicella and herpes zoster byregion and year, in the period between 2008 and 2013. The results were stratified by ageand temporal and geographical distributions characterized. It was also performed a caseseries study including 167 from 175 hospitalizations for chickenpox recorded in FernandesFigueira Institute-Fiocruz in the period between 1997 and 2013, to describe clinical andepidemiological aspects of disease complications. Data from 2.334 deaths and 62.246hospitalizations for chickenpox were collected in DataSUS...
الموضوعات
Humans , Child, Preschool , Child , Chickenpox Vaccine , Hospitalization , Chickenpox/diagnosis , Chickenpox/epidemiology , Chickenpox/mortalityالملخص
El objetivo de estudio fue describir las características clínicas y epidemiológicas de los casos de varicela complicada atendidos en el Instituto Nacional de Salud del Niño (INSN) del Perú durante los años 2001 al 2011. Se realizó una serie de casos que incluyó un total de 1073 niños con varicela complicada. La mediana de la edad fue de 2,5 años (RIQ 1,1-4,8 años); 578 (54%) fueron de sexo masculino. El tipo de complicación más frecuente fueron las infecciones secundarias de piel y partes blandas con 768 casos (72%), se registró 13 (1,4%) fallecidos. En conclusión, en el INSN se hospitalizan con mayor frecuencia casos de varicela complicada en niños menores de cinco años, con un tiempo de hospitalización corto y con una baja proporción de fallecidos, la mayoría de complicaciones siendo relacionadas con las infecciones secundarias de piel y partes blandas.
The objective of the study was to describe the clinical and epidemiological characteristics of complicated chickenpox cases seen at the National Institute of Childrens Health (INSN, Spanish acronym) of Peru from 2001 to 2011. A case series was collected, including a total of 1,073 children with complicated chickenpox. The median age was 2.5 years (IQR 1.1-4.8 years), of which 578 (54%) were male. The most frequent complications were secondary skin and soft tissue infections with 768 cases (72%). 13 deaths (1.4%) were recorded. In conclusion, the hospitalizations due to complicated chickenpox in the INSN included mostly children under five, with a short stay and a low proportion of deaths most complications being related to secondary skin and soft tissue infections.
الموضوعات
Child, Preschool , Female , Humans , Infant , Male , Chickenpox/complications , Chickenpox/diagnosis , Chickenpox/epidemiology , Hospitalization , Hospitals , Hospitals, Pediatric , Peru , Time Factorsالموضوعات
Chickenpox/diagnosis , Chickenpox/epidemiology , Chickenpox/prevention & control , Chickenpox Vaccine/therapeutic use , Female , Humans , Infant, Newborn , Internship and Residency , Pregnancy , Pregnancy Complications, Infectious/diagnosis , Pregnancy Complications, Infectious/epidemiology , Pregnancy Complications, Infectious/prevention & controlالملخص
This study was designed to assess the immune status of the Korean population against varicella-zoster virus (VZV) through a seroepidemiologic study. Residual blood samples were collected from diagnostic laboratories throughout Korea. Samples were collected in October 2009 to March 2010 from persons 0-79 yr of age and were tested by ELISA (Enzygnost(R); Dade Behring, Schwalbach, Germany). Total seroprevalence in subjects 1-79 yr of age was 89.6%. Seroprevalence increased as age increased from 67.3% in subjects 1-4 yr of age to 94.2% in subjects 10-14 yr of age and in subjects over 20 yr of age seroprevalence ranged from 98.0% to 100%. In children under 1 yr of age, passive immunity waned after birth with none of the subjects having antibodies from 7 months of age and over. Among subjects 1-79 yr of age, susceptible subjects to VZV were mainly under 20 yr of age. These results provide information in understanding the dynamics of varicella disease in Korea, which is important in building up strategies for disease control.
الموضوعات
Adolescent , Adult , Aged , Child , Child, Preschool , Female , Humans , Infant , Male , Middle Aged , Young Adult , Antibodies, Viral/analysis , Chickenpox/epidemiology , Enzyme-Linked Immunosorbent Assay , Herpes Zoster/epidemiology , Herpesvirus 3, Human/immunology , Republic of Korea/epidemiology , Seroepidemiologic Studiesالملخص
Infections with varicella-zoster virus (VVZ) in immunocompromised children imply a high mortality. There is no data about VVZ seroprevalence in children with cancer in our country. Aim: To determine the prevalence of VVZ antibodies in children with cancer who have undergone chemotherapy or have undergone a hematopoietic stem cell transplant. Methodology: collaborative, multicenter study. Serum samples were collected from 281 children with cancer and episodes of febrile neutropenia from 6 hospitals belonging to the public health network in the Metropolitan Region between June 2004 and August 2006. These samples were stored at -70 ° C, and 200 of them were randomly chosen and analyzed to determine VVZ IgG (ELISA). Results: 179 samples from 179 children, 65% male. Ninety eigth/179 (55%) were positive, 72/179 (40%) negative and 9/179 (5%) indeterminate. Stratified by age, seropositive percentage was: 1 to 4 years 32%, 5-9 years 42%, 10-14 years 78%, over 15 years 88%. Conclusion: Forty percent of children treated for cancer are seronegative to VVZ infection, a frequency that decreases with age. These results support the adoption of preventive measures to avoid infection in this population of children at risk of developing a serious and possibly fatal illness.
Las infecciones por virus varicela-zoster (VVZ) en niños inmunocomprometidos presentan una alta morbi-mortalidad. Se desconoce la seroprevalencia de VVZ en niños con cáncer en nuestro medio. Objetivo: Determinar la prevalencia de anticuerpos anti VVZ en niños sometidos a tratamiento por cáncer (quimioterapia o trasplante de precursores hematopoyéticos). Método: Estudio colaborativo, multicéntrico. Se recolectaron muestras de suero de 281 niños con cáncer y episodios de neutropenia febril (NF) en seis hospitales de Santiago, entre junio 2004 y agosto 2006 y almacenadas a -70° Cº. Doscientas muestras fueron seleccionadas al azar para determinación de IgG anti VVZ. Resultados: De las 200 muestras de suero obtenidas se excluyeron 21: 12 por ser muestras de un mismo paciente en diferentes episodios de NF y 9 por falta de información. Se analizaron las muestras de 179 niños, 65% de sexo masculino. Noventa y ocho resultaron positivos (55%), 72 negativos (40%) y 9 indeterminados (5%). Estratificado por edad: 1-4 años (32%), 5-9 años (42%), 10-14 años (78%) y mayores de 15 años (88%). Conclusión: 40% de los niños en tratamiento por cáncer son seronegativos para VVZ, condición que disminuye en pacientes con mayor edad. Estos resultados apoyan la adopción de medidas que eviten la infección en esta población de niños con riesgo de desarrollar una enfermedad grave y eventualmente fatal.